J&J | Fremdkapital



Loan Capital Veränderung Datum
AbbVie USD 64.53B 4.19B 2025-03
Abbott USD 12.93B 194M 2025-06
Amgen USD 53.76B 253M 2025-06
AstraZeneca USD 25.99B 1.9B 2025-06
Baxter International USD 9.41B 962M 2025-03
Bayer EUR 31.71B 3.31B 2025-06
Becton, Dickinson and Co. USD 17.53B 135M 2025-06
Biogen USD 6.28B 1.74B 2025-06
Boston Scientific USD 10.53B 1.56B 2025-03
Bristol-Myers Squibb USD 44.47B 1.69B 2025-06
CONMED USD 881.11M 10.33M 2025-06
Cooper Companies USD 2.53B 34.4M 2025-04
Dexcom USD 1.24B 56.7M 2025-06
Edwards Lifesciences USD 597.8M 100K 2025-03
Eli Lilly USD 34.18B 319.4M 2025-06
Gilead Sciences USD 22.14B 6M 2025-06
GlaxoSmithKline GBP 15.3B 1.17B 2025-06
Globus Medical USD 173K 84K 2025-06
Hologic USD 2.51B 37.5M 2025-06
Insulet USD 939M 673.3M 2025-06
Integra LifeSciences USD 1.23B 3.7M 2025-06
Intuitive Surgical USD 0 0 2025-03
J&J USD 38.36B 7.7B 2025-03
Medtronic USD 25.64B 1.66B 2025-04
Merck USD 33.97B 484M 2025-06
Merit Medical Systems USD 731.8M 1.12M 2025-06
Novartis USD 24.06B 2.4B 2025-06
Pfizer USD 57.5B 137M 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2025-06
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.2B 211M 2025-06
Stryker USD 14.83B 446M 2025-06
Tandem Diabetes Care USD 309.15M 4.46M 2025-06
Teva Pharmaceutical Industries USD 16.76B 533M 2025-06
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zimmer Biomet Holdings USD 6.75B 176.2M 2025-06
Zoetis USD 5.23B 4M 2025-06


J&J Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.